Background: It is likely that people with chronic pain who have low self-efficacy have a worse prognosis. A standard, high-quality measure of self-efficacy in such populations would improve evidence, by allowing meaningful comparisons amongst subgroups and between treatments, and by facilitating pooling across studies in systematic reviews.
C hronic pain is a common and costly health problem.
The biopsychosocial model of back pain has improved our understanding of the disorder. Several psychological factors, including self-efficacy have affected prognosis; it may also moderate response to treatment. 1 Self-efficacy (SE) is a concept describing a set of beliefs about oneself, specifically about one's ability to perform certain behaviors within a particular environment. 2 SE is not only related to specific behaviors but also to the beliefs that people have about how they can cope in adverse situations. 3 SE in people suffering from pain include beliefs about one's ability to control the pain and the negative emotions associated with it, to maintain everyday life activities including work, to communicate their needs to health carers, and implement advice about their pain. There is some evidence that higher SE about managing pain is associated with more positive treatment outcomes, 4 higher return to work rates, 5 better adherence, 6 more effective control of pain and effect, 7 and better prognosis. 8 It has also been proposed that SE beliefs mediate the relationship between pain and pain-related disability in different chronic pain samples. 9 Test-retest data has shown that SE is a psychological state that is changeable and therefore modifiable in the context of treatment. 10 Social learning theory suggests that interventions designed to enhance SE of carrying out specific behaviors will be associated with improved healthrelated outcomes in those areas affected by those specific behaviors. 11 A systematic review of lay-led self-management interventions for people with chronic conditions found that SE can be modified, and that improvements in SE can lead to improved quality of life outcomes for patients. 12 Another systematic review (Miles et al, 2010; in preparation) looking at SE as both a predictor and mediator of health-related outcomes after self-management programs found that more positive outcomes were associated with higher baseline SE or with changes in SE as a result of the self-managment intervention (for outcomes including health distress, role-function, pain, disability, and physical function). Standardizing the measurement of SE would benefit research, providing the standard measure comprehensively, and has been shown to be of high clinimetric standards. SE has been measured through self-report questionnaires. Questionnaire choice is usually determined by factors such as time constraints of the questionnaire battery in a study and the population studied, alongside clinimetric merits of the particular scale. Earlier expert consensus studies have made recommendations of measures to improve the quality and completeness of measurement in prospective cohort studies in populations with low back pain and chronic pain. 13, 14 These recommendations did not, however, include SE. There is, therefore, a gap in the literature recommending a measure of SE suitable for chronic pain populations. We are not aware of a systematic review of pain-related SE measures for pain populations followed by clinimetric assessment.
The aim of this study was to review pain-related SE measures that have been used in pain populations (focusing on populations with pain arising from chronic disease or musculoskeletal disorders) systematically and to assess them clinimetrically.
MATERIALS AND METHODS

Stage 1: First Search
We searched Medline and PsycInfo (1950 to September 2010). We used both keywords and Medical Subject Heading terms. Limits of human studies and English language were applied. We used the following search terms: self-efficacy combined with scale, inventory, instrument, measure, outcome, questionnaire, outcome assessment, and psychometrics and this combined with (chronic disease, pain, musculoskeletal diseases, low back pain, fibromyalgia, neck pain, shoulder pain, osteoarthritis, chronic, persistent, long term, wide spread, recurrent, nonspecific, ongoing, or musculoskeletal).
Inclusion Criteria
We included studies if they were published in a peerreviewed journal and were used with adults with pain as either a result of chronic disease or musculoskeletal disorders and the item content explicitly included painrelated SE.
Stage 2: Second Search
We selected pain-related SE measures for further clinimetric-focused searching on the basis of the following criteria: (1) The tool was used in at least 1 study in a pain population (chronic disease or musculoskeletal disorder);
(2) The tool was presented in English and the measures that fulfilled these criteria from the first search were selected for focus in a second search; and (3) The content of the questionnaire items explicitly included the term "pain." The second search attempted to identify clinimetric evaluation of these SE measures and used the names of these questionnaires. Search terms used were: Arthritis selfefficacy, Chronic Disease self-efficacy, Stanford self-efficacy, Pain self-efficacy, PSEQ, Chronic Pain Self-efficacy Scale, CPSS, Self-Efficacy Scale, SES, Movement and Pain-Prediction Scale, or MAPPS combined with Test Reliability, exp Psychometrics, exp Test Validity, exp Test Interpretation, validity, reliability, development, consistency, responsiveness, interpretability, psychometrics, and clinimetrics. The reference lists of the identified psychometric studies were scanned to obtain further psychometric studies.
Stage 3: Clinimetric Assessment
We carried out clinimetric assessment on the painrelated SE questionnaires selected at stage 2. We assessed these studies using the clinimetric criteria adopted from earlier research 15, 16 and included information regarding the following: time to administer, ease of scoring, readability and comprehension, content validity, internal consistency, criterion validity, construct validity, reproducibility (agreement and reliability), responsiveness, interpretability, and floor/ceiling effects. Table 3 presents the scoring criteria and definitions.
RESULTS
The first electronic search identified 1520 articles-180 of these were screened for inclusion in this review. Table 1 presents the questionnaires that were obtained from the first broad search. There were 13 pain-related SE questionnaires identified in the search (Table 1) . On closer inspection, we excluded 8 measures as they were either not pain-related SE measures, leaving 6 pain-related SE measures. These were: (1) The Arthritis Self-Efficacy Scale (ASES) 10 and its 2 variants (shorter versions); (2) The Chronic Disease Self-Efficacy Scale (CDSES) 44 and its 1 variant (shorter version); (3) The Pain Self-Efficacy Questionnaire (PSEQ) 27 ; (4) The Chronic Pain Self-efficacy Scale (CPSS) 17 ; (5) The Self-Efficacy Scale (SES) 33 ; and (6) The Movement and Pain Prediction Scale.
The second search identified a further 80 references for the ASES, CDSES, PSEQ, CPSS, and SES. In the end, 35 references included clinimetric evaluation and 85 references that used the main questionnaires. There were no studies that included clinimetric evaluation of the Movement and Pain Prediction Scale. 49 Figure 1 presents a detailed search process.
Descriptives of the Questionnaires
There are 3 versions of the ASES (short and long versions, ASES-20, 10 ASES-11, 10 and ASES-8 10 ) two CDSES (short and long versions, CDSES-33 and CDSES-6 44, 45 ), the PSEQ, 27 the CPSS, 17 and the SES (Altmaier et al, 1993) . Descriptives regarding the domains measured, numbers of scales and items, time to administer, burden of scoring, and target populations are presented in Table 2 . All questionnaires were scored easily as defined by Bot et al. 15 Time to administer was generally under 10 minutes. Where times were not available for 4 questionnaires (ASES-20, CPSS, CDSES-30, and SES), it is estimated at 10 to 15 minutes for the ASES-20, CPSS, and SES and 15 to 20 minutes for the CDSES-30. It is also important to note that the CPSS is an adaptation of the original version of the ASES. The items of the ASES were adapted for use with a general chronic pain population and are very similar in item content. The CPSS has 2 additional items and different behaviors are used to the ASES.
Readability and Comprehensibility
Readability and comprehensibility were assessed in 3 questionnaires (PSEQ, ASES-11, and CPSS). No information on either readability or comprehension was provided for the other questionnaires.
Content Validity
Ratings regarding the content validity and other clinimetric domains are presented in Table 3 . The majority of the questionnaires rated positively for content validity. There was not enough information provided for assessment in the CDSES-6 and the SES.
Internal Consistency
Factor analysis and Principal Components Analysis showed presence of factors for the ASES-20 (3 factors), ASES-11 (2 factors), PSEQ (1 factor), and CPSS (3 factors). Internal consistency was studied in all of the questionnaires and Cronbach a ranged from 0.76 to 0.98 and is given a positive rating if more than 0.70. 56 Item Reduction was carried out only for ASES-20 and SES. Confirmatory Factor Analysis was only carried out for the ASES-20.
Criterion Validity
As there is no "gold standard" of SE measure against which the evaluated questionnaires could be compared, however, this quality was assessed where other SE measures were used as a comparator. None of the questionnaires scored positively on criterion validity. The correlations were less than 0.70 for the ASES-20 and ASES-11. The method was doubtful or there was no justification given for using the comparator SE measure with the CDSES-33.
There was not enough information provided for assessing criterion validity on the ASES-8, CDSES-6, PSEQ, CPSS, and SES.
Construct Validity
Construct validity was showed for all measures, except the CDSES-6 and the SES, through correlations of the SE measures with various outcomes. Hypotheses were given regarding expected relationships, although not always directional. Outcomes were depression, psychological well-being, reported pain and fatigue, positive effect, pain-related disability, and pain-coping strategies (among the ASES scales). PSEQ scores were correlated with depression, anxiety, unhelpful coping strategies, pain ratings, somatic focusing, 
Reproducibility Agreement
To calculate the agreement of a questionnaire, the minimal important change (MIC) and the smallest detectable change should be provided by the researchers constructing the questionnaire. This information was not provided for all questionnaires reviewed here and therefore agreement could not be calculated.
Reliability
Test-retest reliability was assessed for 4 of the 8 questionnaires (ASES-20, CDSES-33, PSEQ, and CPSS). Time intervals between test administrations were between 3 days and 16.3 weeks. Test-retest correlations ranged from 0.68 to 0.88 across the 4 questionnaires. Pearson product correlations were used to assess test-retest reliability for the ASES-20, CDSES-33, and PSEQ; however the intraclass correlation coefficient is thought to be the most adequate test of retest-reliability 57 and was carried out for the CPSS only.
Responsiveness
The responsiveness of 5 of the questionnaires (ASES-20, CDSES-33, PSEQ, CPSS, and SES) was evaluated in 8 studies. Hypotheses were given from all studies (except Burckhardt et al 39 ) regarding a specific change in SE in association with the intervention (note that a change was explored in study by Nicholas et al, 27 but was not predicted). No data on responsiveness were found for the other 3 questionnaires (ASES-11, ASES-8, and CDSES-6). Recent recommendations suggest that an adequate way to analyze responsiveness is through receiver operating characteristic curve analysis or by relating the smallest detectable change to the MIC. 16 No study used these Exclusions: 38 dissertations, 3 books, 2 reviews; 21 did not fit the inclusion criteria of chronic pain populations, including musculoskeletal conditions. Stage 1: 180 references. From these 6 pain-related self-efficacy measures were found.
Stage 2:
80 references were identified from the second search focusing on clinimetric evaluation of the 6 self-efficacy questionnaires.
Stage 2: 34/80 references included clinimetric evaluation of 5 out of 6 of the self-efficacy questionnaires (one questionnaire dropped from further assessment due to no studies retrieved including clinimetric evaluation.
Stage 3:
Clinimetric assessment of the final five pain-related self-efficacy questionnaire ? indicates time taken to complete not reported; ASES, Arthritis Self-Efficacy Scale; CDSES, Chronic Disease Self-Efficacy Scale; CPSS, Chronic Pain Self-Efficacy Scale; PSEQ, Pain Self-Efficacy Questionnaire; SES, Self-Efficacy Scale. techniques to analyze responsiveness and therefore, there were no positive ratings given for this measure.
Floor/Ceiling Effects
Floor and ceiling effects were evaluated for the ASES-8 and CDSES-33 by calculating the proportions of the sample that had the lowest and highest possible scores. Both questionnaires were free from floor effects, although minimal ceiling effects was reported for the CDSES-33. Such information was missing for the ASES-20, ASES-11, CDSES-6, PSEQ, CPSS, and SES.
Interpretability
None of the questionnaires scored positively for providing adequate interpretability data. Although baseline and post-means were given for 4 questionnaires (ASES-20, CDSES-33, PSEQ, and CPSS) and scores of a relevant subgroup was described for the PSEQ, minimal clinically important differences (MCID) were not reported for any of the SE measures and there was no interpretability data available for the other 4 questionnaires (ASES-11, ASES-8, CDSES-6, or SES).
Versions in Other Languages
The PSEQ has been translated into Persian, Portuguese, and Chinese [29] [30] [31] ; the ASES has Swedish, Spanish, and German versions [46] [47] [48] 58 ; the CPSS has Spanish and Chinese versions 25, 26 ; and the SES has a Swedish version. 59 
DISCUSSION
To our knowledge, this study was the first to systematically search pain-related SE questionnaires and carry out clinimetric assessment of them. This review did not intend to provide recommendation of the "best" tool to use in research but rather to provide information to researchers about the range of pain-related SE questionnaires and their clinimetric qualities to aid selection.
We identified 13 pain-related SE questionnaires and clinimetrically assessed 5 (8, including variants) of these questionnaires (ASES, CDSES, PSEQ, CPSS, and SES). These questionnaires were identified as being used in those with pain as a result of chronic disease or musculoskeletal disorders. Three questionnaires (CDSES, CPSS, and PSEQ) are more suitable for chronic pain populations in general. For the development of these questionnaires, the CDSES used a heterogeneous pain group, whereas for the PSEQ and CPSS, the populations were predominantly those with musculoskeletal disorders. The ASES was designed specifically for patients with arthritis and the SES was developed in a low back pain population. The populations in which the questionnaires were validated in should be considered when selecting measures for use in other populations. Furthermore, this review is limited to these populations and should not be generalized to other pain populations.
Future research should aim to explore the meaning of different score ranges within each questionnaire. This would improve understanding by relating scores to clinical status. None of the studies provided MCIDs. The MCID is "the smallest (absolute) difference in score which patients perceive as beneficial and which would mandate, in the absence of troublesome side-effects and excessive cost, a change in the patient's management" (http://www.jrheum. com/subscribers/07/03/463.html). 60 There have been developments in the assessment of MCID, 61 split the analysis into a minimal important difference and MIC, however, none of the questionnaires in this study measured either. For some of the questionnaires, there was some information that could assist with interpretation of the scores, such as presentation of means and SDs of patient scores before and after treatment, however, information regarding relevant subgroups was provided for the PSEQ only.
Overall, there was disappointment that these are not better validated but inadequate validation is common across a range of domains that are measured through self-report questionnaires. On the basis of the review of these questionnaires, we make recommendations for future researchers carrying out validation of questionnaires of SE: (1) factor structures of questionnaires should be explored and confirmed; (2) when testing construct validity, specify directional hypotheses; (3) provide descriptive statistics for distribution of scores for adequate evaluation of floor/ ceiling effects; (4) test-retest data and interrater reliability data using adequate statistical procedures need to be carried out; and (5) information regarding the interpretability of scores should be provided or other information such as scores of relevant subgroups and means and SDs to aid comparability and responsiveness.
The research team for this review decided upon aspects thought to be important in SE in pain populations. These are outlined in the introduction as beliefs about one's ability to control the pain and the negative emotions associated with it; to maintain everyday life activities including work; to communicate their needs to health carers; and implement advice about their pain. The ASES and CPSS address most of these aspects of SE, but do not include items that cover communication with their health carers. The CDSES covers all aspects of these SE criteria, whereas the PSEQ only addresses confidence to maintain everyday lives. The SES focuses purely on activities of daily living and items do not address any of the above. Additional research is needed before final decisions about the important aspects of SE can be made. Patient-centered research should address the issue of what should be included in a truly comprehensive evaluation of painrelated SE.
SE is not only related to specific behaviors but also to the beliefs that people have about how they can cope in adverse situations. 3 For a questionnaire to measure, SE it is important that both components are covered in the questionnaire items. All the questionnaires we assessed featured items that ask about patients' coping and about their beliefs in relation to their own behaviors. However, it could be argued that this is not situation-specific enough. For example, "I can enjoy things, despite my pain," may be too general a question, and may not tap beliefs about specific behaviors that have been affected by pain. Negative beliefs about a small range of very specific behaviors may be incredibly detrimental to patients' coping and adjustment, but maybe obscured if items ask only general questions. Clearly, it is difficult to measure SE using such a general tool when SE is sensitive to specific behaviors. One idea is to use a more patient-centered instrument in which individuals indicate the specific behaviors associated with their own personal SE, beliefs, behaviors, and goals that also measures obstacles to effective coping, for example, Measure Yourself Medical Outcome Profile (MYMOP). 62 MYMOP aims to measure the outcomes that the patient considers the most important. On the first occasion, the questionnaire is completed within the consultation, or with some confidential help. The patient chooses 1 or 2 symptoms that they are seeking help with, and that they consider to be the most important. The MYMOP has been shown to be practical, reliable, and sensitive to change. 62 This method can be applied to any measurement construct and is directly applicable to the patient, leading to high response and completion rates. There are several individualized measures available that could be used, 1 example of which is the MYMOP. However, to our knowledge, there is no investigation of the use of the MYMOP to measure SE. Furthermore, the MYMOP cannot be completed as a purely self-administered tool, as it requires initial guidance and therefore, is not suitable for studies using only postal questionnaires. The method does, however, place high reliance on patient self-awareness of their problem areas and problematic in economic evaluations because of the individualized nature of the data.
Limitations
Despite our efforts to carry out a systematic and comprehensive search, it is possible that we missed important target articles. Our search was limited to Medline and PsycInfo, and although there is evidence that Medline is superior to other databases in its discriminating power and comprehensiveness, 63 a wider search may have yielded further publications. We note, however, that we have reviewed the most commonly used instruments, and have been able to retrieve information on most aspects of their clinimetric properties. Another limitation is our focus on the label "selfefficacy" alone: There are no doubt many overlapping concepts, such as patient enabling, locus of control, etc. However, generating all the overlapping terms and searching for them would yield an unmanageable amount of data. In addition, it is not clear how much shared and unique variance each concept has with SE, such a conceptual analysis was beyond the scope of this study.
In summary, on the basis of the published information at this point in time, we were able to identify 5 good candidates for use in measurement of SE in pain populations. All 5 measures follow social learning theory in terms of measuring SE for coping in adverse situations, although it can be argued that some items in all the reviewed questionnaires are not situation-specific. Further researchers need to be aware that the clinimetric limitations are variable across questionnaires. Researchers are encouraged to continue the development of these questionnaires in reference to interpretability and responsiveness of the scales, particularly in the shorter versions of the ASES and the CDSES. Where the existing measures are not appropriate, we acknowledge that a more patient-centered approach, such as MYMOP could be used. Furthermore, outcome expectations need to be measured alongside SE to best predict future behavior.
